138 related articles for article (PubMed ID: 11745220)
21. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant chemotherapy with tegafur/uracil for more than 1 year improves disease-free survival for low-risk Stage II colon cancer.
Hu JM; Chou YC; Wu CC; Hsiao CW; Lee CC; Chen CT; Hu SI; Liu WT; Jao SW
J Chin Med Assoc; 2016 Sep; 79(9):477-88. PubMed ID: 27329402
[TBL] [Abstract][Full Text] [Related]
23. Multivisceral resection for colon carcinoma.
Croner RS; Merkel S; Papadopoulos T; Schellerer V; Hohenberger W; Goehl J
Dis Colon Rectum; 2009 Aug; 52(8):1381-6. PubMed ID: 19617748
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of clinical, pathological and immunohistochemical markers in stage II colon cancer patients.
Stor Z; Frković GS; Bracko M; Repse S
Acta Chir Iugosl; 2008; 55(3):39-44. PubMed ID: 19069691
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy.
Zhao S; Jiang T; Tang H; Cui F; Liu C; Guo F; Lu H; Xue Y; Jiang W; Peng Z; Yan D
J Gastroenterol Hepatol; 2015 Apr; 30(4):680-8. PubMed ID: 25238407
[TBL] [Abstract][Full Text] [Related]
26. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
Matsuda C; Ishiguro M; Teramukai S; Kajiwara Y; Fujii S; Kinugasa Y; Nakamoto Y; Kotake M; Sakamoto Y; Kurachi K; Maeda A; Komori K; Tomita N; Shimada Y; Takahashi K; Kotake K; Watanabe M; Mochizuki H; Nakagawa Y; Sugihara K;
Eur J Cancer; 2018 Jun; 96():54-63. PubMed ID: 29677641
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
Cakar B; Varol U; Junushova B; Muslu U; Gursoy Oner P; Gokhan Surmeli Z; Cirak Y; Karaca B; Sezgin C; Karabulut B; Uslu R
J BUON; 2013; 18(2):372-6. PubMed ID: 23818348
[TBL] [Abstract][Full Text] [Related]
28. Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis.
Miyamoto Y; Hayashi N; Sakamoto Y; Ohuchi M; Tokunagam R; Kurashige J; Hiyoshi Y; Baba Y; Iwagami S; Yoshida N; Yoshida M; Baba H
Int J Clin Oncol; 2015 Dec; 20(6):1140-6. PubMed ID: 25947545
[TBL] [Abstract][Full Text] [Related]
29. Selection of colon cancer patients for neoadjuvant chemotherapy by preoperative CT scan.
Nørgaard A; Dam C; Jakobsen A; Pløen J; Lindebjerg J; Rafaelsen SR
Scand J Gastroenterol; 2014 Feb; 49(2):202-8. PubMed ID: 24279811
[TBL] [Abstract][Full Text] [Related]
30. Influence of pT3 subgroups on outcome of R0-resected colorectal tumors.
Mrak K; Jagoditsch M; Leibl S; Klingler A; Tschmelitsch J
South Med J; 2011 Nov; 104(11):722-30. PubMed ID: 22024778
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial.
Sadahiro S; Suzuki T; Ishikawa K; Yasuda S; Tajima T; Makuuchi H; Saitoh T; Murayama C
Cancer; 2004 Feb; 100(3):590-7. PubMed ID: 14745877
[TBL] [Abstract][Full Text] [Related]
32. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients.
Greene FL; Stewart AK; Norton HJ
Ann Surg; 2002 Oct; 236(4):416-21; discussion 421. PubMed ID: 12368669
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
[TBL] [Abstract][Full Text] [Related]
34. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
[TBL] [Abstract][Full Text] [Related]
35. Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
Cienfuegos JA; Martínez P; Baixauli J; Beorlegui C; Rosenstone S; Sola JJ; Rodríguez J; Hernández-Lizoáin JL
Ann Surg Oncol; 2017 Apr; 24(4):1077-1084. PubMed ID: 27624582
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
37. Laparoscopic colectomy for cancer: Improved compliance with guidelines for chemotherapy and survival.
Kim RH; Kavanaugh MM; Caldito GC
Surgery; 2017 Jun; 161(6):1633-1641. PubMed ID: 28027818
[TBL] [Abstract][Full Text] [Related]
38. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
[TBL] [Abstract][Full Text] [Related]
39. Direct tumor invasion in colon cancer: correlation with tumor spread and survival.
Wong SK; Jalaludin BB; Henderson CJ; Morgan MJ; Berthelsen AS; Issac MM; Kneebone A
Dis Colon Rectum; 2008 Sep; 51(9):1331-8. PubMed ID: 18551346
[TBL] [Abstract][Full Text] [Related]
40. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer.
Law CH; Wright FC; Rapanos T; Alzahrani M; Hanna SS; Khalifa M; Smith AJ
J Surg Oncol; 2003 Nov; 84(3):120-6. PubMed ID: 14598354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
